Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis

BACKGROUND & AIMS: Cirrhosis is associated with immune dysregulation and hyporesponsiveness to several vaccines including those against COVID-19. Our aim was to compare outcomes between patients with cirrhosis who received 3 doses of either the Pfizer BNT162b2 mRNA or Moderna mRNA-1273 vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: John, Binu V., Ferreira, Raphaella D., Doshi, Akash, Kaplan, David E., Taddei, Tamar H., Spector, Seth A., Paulus, Elizabeth, Deng, Yangyang, Bastaich, Dustin, Dahman, Bassam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519143/
https://www.ncbi.nlm.nih.gov/pubmed/36181987
http://dx.doi.org/10.1016/j.jhep.2022.07.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519143/
https://www.ncbi.nlm.nih.gov/pubmed/36181987
http://dx.doi.org/10.1016/j.jhep.2022.07.036

Ejemplares similares